Trudell Medical International Release: HFA Transition Provides an Opportunity to Improve Aerobid(R) Inhaler

LONDON, Ontario--(BUSINESS WIRE)--Trudell Medical International is pleased to announce the selection of the AEROCOUNT® Dose Indicator for use with Forest’s proprietary product containing the active ingredient Flunisolide in an HFA formulation.